Close Menu

Hitachi

Du Pont has been awarded

NEW YORK (GenomeWeb) − One challenge developers of nanopore sequencing technologies have been facing is DNA passing through the pores too quickly to detect its sequence with single-base resolution.

NEW YORK (GenomeWeb) – Annai Systems said today that it is working with Hitachi Data Systems to provide an integrated data management and analysis system that combines Hitachi's high-performance compute and cloud-based solutions and the Annai-GNOS data management software platform.

Title: Method for reconstructing evolutionary data
US Patent Number: 8,645,074
Assignee: International Business Machines

Title: Methods and compositions for base calling nucleic acids
US Patent Number: 8,612,161

NEW YORK (GenomeWeb News) – A group of bioinformatics and technology-focused firms and institutes that challenges informatics researchers to solve specific problems, has issued a new challenge to spur investigators to develop better methods for identifying cancer-associated mutations.

Hitachi High-Technologies has been awarded US Patent No. 8,574,891, "Nucleic acid analyzer, automatic analyzer, and analysis method."
Kohshi Maeda, Masato Ishizawa, Minoru Sano, and Hironori Kaji are named as inventors.

NEW YORK (GenomeWeb News) – The University of California, Santa Cruz said today that Hitachi has sponsored a new cancer genomics research agreement with the university, under which the company will provide research funding and a data storage system that together total over $1 million in support.

Last week, Base4 Innovation said it plans to collaborate with Hitachi to develop a solid-state nanopore sequencer.

US Patent 8,433,522. Information processing system using nucleotide sequence-related information. Inventors: Takamasa Kato, Takeo Morimoto. Assignee: Hitachi

Pages

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.